Position in ARGX
as of Jun 30, 2026
· filed Aug 12, 2026
Position Value
$22,137,519
+$4,926,257 QoQ
Shares Held
23,861
+1.2% QoQ
Ownership
0.038%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#88
of 505 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in ARGX Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026GEODE CAPITAL MANAGEMENT, LLC holds $21,877,569,550 across 521 Biotechnology names. ARGX ranks #129 (0.1% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
6,017,848 | $2,989,245,636 | |
| 2 | REGN |
Regeneron Pharmaceuticals, Inc.
|
2,625,810 | $1,637,297,566 | |
| 3 | ALNY |
Alnylam Pharmaceuticals, Inc.
|
2,635,840 | $793,466,914 | |
| 4 | RVMD |
Revolution Medicines, Inc.
|
3,942,676 | $738,384,360 | |
| 5 | MRNA |
Moderna, Inc.
|
9,710,335 | $680,014,759 | |
| 6 | INCY |
Incyte Corp
|
4,750,735 | $538,543,319 | |
| 7 | RPRX |
Royalty Pharma plc
|
8,058,048 | $451,814,751 | |
| 8 | INSM |
INSMED Inc
|
4,220,155 | $449,952,925 |
All Filings in ARGX
Export CSV
26 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $22,137,519 | 23,861 | Shares | Defined | 2026-08-12 | |
| 2026-03-31 | $17,211,262 | 23,569 | Shares | Defined | 2026-05-15 | |
| 2025-12-31 | $19,926,310 | 23,695 | Shares | Defined | 2026-02-09 | |
| 2025-09-30 | $19,260,641 | 26,114 | Shares | Defined | 2025-11-12 | |
| 2025-06-30 | $14,473,383 | 26,257 | Shares | Defined | 2025-08-08 | |
| 2025-03-31 | $15,733,547 | 26,583 | Shares | Defined | 2025-05-13 | |
| 2024-12-31 | $16,732,305 | 27,207 | Shares | Defined | 2025-02-12 | |
| 2024-09-30 | $14,500,097 | 26,749 | Shares | Defined | 2024-11-12 | |
| 2024-06-30 | $11,676,446 | 27,152 | Shares | Defined | 2024-08-09 | |
| 2024-03-31 | $10,326,488 | 26,228 | Shares | Defined | 2024-05-13 | |
| 2023-12-31 | $9,857,702 | 25,912 | Shares | Defined | 2024-02-13 | |
| 2023-09-30 | $11,974,631 | 24,357 | Shares | Defined | 2023-11-13 | |
| 2023-06-30 | $9,489,146 | 24,348 | Shares | Defined | 2023-08-11 | |
| 2023-03-31 | $9,050,340 | 24,291 | Shares | Defined | 2023-05-15 | |
| 2022-12-31 | $9,152,153 | 24,159 | Shares | Defined | 2023-02-13 | |
| 2022-09-30 | $10,856,993 | 30,752 | Shares | Defined | 2022-11-14 | |
| 2022-06-30 | $11,346,698 | 29,948 | Shares | Defined | 2022-08-12 | |
| 2022-03-31 | $6,530,700 | 20,712 | Shares | Defined | 2022-05-13 | |
| 2021-12-31 | $7,629,239 | 21,786 | Shares | Defined | 2022-02-11 | |
| 2021-09-30 | $6,629,202 | 21,951 | Shares | Defined | 2021-11-12 | |
| 2021-06-30 | $7,295,528 | 24,232 | Shares | Defined | 2021-08-13 | |
| 2021-03-31 | $5,511,655 | 20,014 | Shares | Defined | 2021-05-12 | |
| 2020-12-31 | $5,814,747 | 19,772 | Shares | Defined | 2021-02-12 | |
| 2020-09-30 | $5,298,178 | 20,182 | Shares | Defined | 2020-11-13 | |
| 2020-06-30 | $4,025,310 | 17,872 | Shares | Defined | 2020-08-13 | |
| 2020-03-31 | $2,131,523 | 16,181 | Shares | Defined | 2020-05-14 | |
| No filing history on record for this holder in this stock. | ||||||